Learn More About the PROCADE Trial

The PROCADE Trial is a randomized study in metastatic castration-resistant prostate cancer (mCRPC), which is cancer that has spread (metastasized) beyond the prostate gland and for which initial hormone therapy is no longer effective in stopping or slowing the disease.

The purpose of this site is to educate patients and health care professionals about the ongoing research in this area and opportunities for patient enrollment.